Tower Research Capital LLC (Trc) Pacira Bio Sciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,624 shares of PCRX stock, worth $113,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,624
Previous 1,411
227.71%
Holding current value
$113,657
Previous $35,000
214.29%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding PCRX
# of Institutions
257Shares Held
51.4MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$197 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$133 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$58.9 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$55.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$52.9 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.13B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...